Clinical Trial

The Clinical Course and Factors for the Progression of Uninvestigated Dyspepsia to Functional Dyspepsia

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 26, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Dyspepsia is one of the most common gastrointestinal diseases. This disease was defined as predominant epigastric pain lasting for at least 1 month, which can be accompanied with other symptoms, such as epigastric fullness, and early satiety. Despite dyspepsia symptoms lasting for ≥1 month represented clinical problem, a longer duration of 6 months or more after first-onset symptom was required for the diagnosis of functional dyspepsia based on ROME IV criteria. It was unclear about the natural procession of first-onset dyspepsia to functional dyspepsia assessed by Rome IV or Asia criteria and possible factors associated with this progression.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-04-10.
Trial Details
NCT Number NCT05823636
Lead Sponsor Air Force Military Medical University, China
Conditions Dyspepsia
Enrollment 220 participants
Start Date 2023-01-01
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-26